Biotalys NV reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was EUR 22.73 million compared to EUR 16.93 million a year ago. Basic loss per share from continuing operations was EUR 0.74.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.04 EUR | +1.33% | -2.56% | -34.90% |
Mar. 18 | Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development | MT |
Mar. 18 | Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.90% | 103M | |
+0.02% | 7.34B | |
+7.85% | 3.17B | |
+11.82% | 843M | |
-3.78% | 357M | |
+14.12% | 296M |
- Stock Market
- Equities
- BTLS Stock
- News Biotalys NV
- Biotalys NV Reports Earnings Results for the Full Year Ended December 31, 2022